Combination therapies with mitogen-activated protein kinase kinase inhibitors and immune checkpoint inhibitors in non-small cell lung cancer

Detalles Bibliográficos
Autores principales: Xu, Jia-Li, Wang, Xin-Zhu, Jiang, Hu-Ning, Chen, Yi, Wang, Rong, Shu, Yong-Qian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Medical Progress
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575179/
https://www.ncbi.nlm.nih.gov/pubmed/32941237
http://dx.doi.org/10.1097/CM9.0000000000001070
_version_ 1783597762597617664
author Xu, Jia-Li
Wang, Xin-Zhu
Jiang, Hu-Ning
Chen, Yi
Wang, Rong
Shu, Yong-Qian
author_facet Xu, Jia-Li
Wang, Xin-Zhu
Jiang, Hu-Ning
Chen, Yi
Wang, Rong
Shu, Yong-Qian
author_sort Xu, Jia-Li
collection PubMed
description
format Online
Article
Text
id pubmed-7575179
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-75751792020-10-29 Combination therapies with mitogen-activated protein kinase kinase inhibitors and immune checkpoint inhibitors in non-small cell lung cancer Xu, Jia-Li Wang, Xin-Zhu Jiang, Hu-Ning Chen, Yi Wang, Rong Shu, Yong-Qian Chin Med J (Engl) Medical Progress Lippincott Williams & Wilkins 2020-10-20 2020-09-15 /pmc/articles/PMC7575179/ /pubmed/32941237 http://dx.doi.org/10.1097/CM9.0000000000001070 Text en Copyright © 2020 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0
spellingShingle Medical Progress
Xu, Jia-Li
Wang, Xin-Zhu
Jiang, Hu-Ning
Chen, Yi
Wang, Rong
Shu, Yong-Qian
Combination therapies with mitogen-activated protein kinase kinase inhibitors and immune checkpoint inhibitors in non-small cell lung cancer
title Combination therapies with mitogen-activated protein kinase kinase inhibitors and immune checkpoint inhibitors in non-small cell lung cancer
title_full Combination therapies with mitogen-activated protein kinase kinase inhibitors and immune checkpoint inhibitors in non-small cell lung cancer
title_fullStr Combination therapies with mitogen-activated protein kinase kinase inhibitors and immune checkpoint inhibitors in non-small cell lung cancer
title_full_unstemmed Combination therapies with mitogen-activated protein kinase kinase inhibitors and immune checkpoint inhibitors in non-small cell lung cancer
title_short Combination therapies with mitogen-activated protein kinase kinase inhibitors and immune checkpoint inhibitors in non-small cell lung cancer
title_sort combination therapies with mitogen-activated protein kinase kinase inhibitors and immune checkpoint inhibitors in non-small cell lung cancer
topic Medical Progress
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575179/
https://www.ncbi.nlm.nih.gov/pubmed/32941237
http://dx.doi.org/10.1097/CM9.0000000000001070
work_keys_str_mv AT xujiali combinationtherapieswithmitogenactivatedproteinkinasekinaseinhibitorsandimmunecheckpointinhibitorsinnonsmallcelllungcancer
AT wangxinzhu combinationtherapieswithmitogenactivatedproteinkinasekinaseinhibitorsandimmunecheckpointinhibitorsinnonsmallcelllungcancer
AT jianghuning combinationtherapieswithmitogenactivatedproteinkinasekinaseinhibitorsandimmunecheckpointinhibitorsinnonsmallcelllungcancer
AT chenyi combinationtherapieswithmitogenactivatedproteinkinasekinaseinhibitorsandimmunecheckpointinhibitorsinnonsmallcelllungcancer
AT wangrong combinationtherapieswithmitogenactivatedproteinkinasekinaseinhibitorsandimmunecheckpointinhibitorsinnonsmallcelllungcancer
AT shuyongqian combinationtherapieswithmitogenactivatedproteinkinasekinaseinhibitorsandimmunecheckpointinhibitorsinnonsmallcelllungcancer

Ejemplares similares